Source-linked · Corrected · Current

The Signal

Source-linked intelligence on policy, markets, health, AI, technology, and the forces shaping high-performance decisions.

The observation layer

Every Signal updates a larger map.

Explore the As Above Intelligence System ... eight lenses, four cross-asset claims, explicit scenarios, and the relationships that decide the next regime.

Open the Regime Map →

Recent Signals

// Updated Sep 14, 2026
Oikos · Global Macro
SEP 14, 2026

The Bond Hedge Is Changing

The 60/40 portfolio is not dead. Its bond hedge is conditional. Rebuild defense around liquidity, recession convexity, inflation resilience, and monetary scarcity.

Read the feature →
Pneuma · Soma · Techne
SEP 13, 2026

The Laser Did Not Write the Code

A red laser pattern plus N,N-DMT produces recurring reports of script-like forms. That is evidence about perception under a scaffold, not proof of the operating system of reality.

Read the feature →
Techne · Physical AI · Oikos
SEP 11, 2026

The Line Walked. The Invoice Did Not.

A commissioned humanoid line is not yet a shipment log. Follow the capital cycle from compute and components into accepted plant hours, independent revenue, and the second invoice.

Read the feature →
Techne · The Agent Economy
SEP 3, 2026

The Computer Will Act. That Is Not AGI.

Astra can operate the computer. The unfinished layer is identity, mandate, monitorability, revocation, and a named principal who answers for the click.

Read the feature →
Robotics + Physical AI
AUG 30, 2026

The Verification Layer Between AI and Physical Action

Capability is not permission. A bounded satellite experiment frames the evidence, operating checks and economics between an AI proposal and accepted physical work.

Read the feature →
Robotics + Physical AI
AUG 30, 2026

The Robotics Trade Is a Bottleneck Trade

Better robot brains are not the whole business. Follow useful work, migrating constraints, customer economics, and who retains the value.

Read the feature →
Techne · The Agent Economy
AUG 29, 2026

Who Acts When Intelligence Leaves the Chat Window?

The Hugging Face agent incident, physical control standards, and machine payments reveal the unfinished layer: identity, authority, revocation, and accountability.

Read the feature →
Neuroscience + Consciousness
AUG 23, 2026

The Brain Does Not Change in a Vacuum

Why plasticity is shaped by activity, context, attention, and what happens afterward—and why chemistry is never the whole experience.

Read the feature →
Market Architecture
AUG 22, 2026

Gold Is Insurance. Bitcoin Is Optionality.

Why two scarce monetary assets have different buyers, shock behavior, portfolio functions, and regime signals.

Full analysis →
Markets + Monetary Regimes
AUG 22, 2026

The Market Is Voting Twice

Stocks price resilience while bonds, gold, and Bitcoin transmit competing signals about inflation, liquidity, and monetary credibility.

Full analysis →
Artificial Intelligence
UPDATED AUG 4, 2026

Chinese Open Models Reach Nearly 30% of OpenRouter Use in Peak Weeks

OpenRouter's State of AI report says Chinese open-weight models averaged about 13% of weekly token volume and approached 30% in some weeks, with important limits.

Full story →
Health + Consciousness
UPDATED AUG 4, 2026

In a Mouse Model, Microglia Drive Amyloid-Linked Sleep Loss

A 2026 mouse study linked overactive microglia to sleep loss in an amyloid model. Depleting those cells restored more than two hours of sleep without reducing amyloid.

Full story →
Health + Markets
UPDATED AUG 4, 2026

Lilly Agrees to Acquire AtaiBeckley in a Deal Worth Up to $3.8 Billion

Eli Lilly agreed to acquire AtaiBeckley for $6.75 per share in cash plus a contingent value right worth up to $2.50 per share, subject to milestones.

Full story →
Markets + Technology
UPDATED AUG 4, 2026

The Fed Held. AI Capital Spending Accelerated.

The Federal Reserve held rates at 3.5% to 3.75% while Microsoft, Meta, and Amazon reported rapid AI growth and heavy infrastructure investment.

Full story →
Health
UPDATED AUG 4, 2026

First Oral PCSK9 Inhibitor Approved, Expanding LDL-Lowering Options

The FDA approved Merck's once-daily Lipfendra, the first oral PCSK9 inhibitor, as an adjunct to diet and exercise for adults with hypercholesterolemia.

Full story →
Policy + Geopolitics
UPDATED AUG 4, 2026

USTR Sets New Tariffs After Forced-Labor Import-Ban Investigations

USTR announced Section 301 tariffs on products from 60 economies after investigations of whether they failed to adopt or enforce forced-labor import bans.

Full story →
Markets
UPDATED AUG 4, 2026

The Trump Trade Is Splintering, Not Moving as One Basket

Public fund data show a wide gap among policy-linked themes. Infrastructure has advanced while defense technology has lagged, arguing against one Trump Trade basket.

Full story →
Policy + Health
UPDATED AUG 4, 2026

FDA Reviews Seven Peptides for Compounding; Final Action Is Pending

The FDA's July 2026 advisory meeting reviewed seven bulk peptide substances for 503A compounding. Official materials do not yet establish a final FDA action.

Full story →

Get the Signal in your inbox

The most important thing that happened today, distilled. No filler. No spam. For high performers who read to move.

Subscribe to the Signal →